Patients with sporadic pituitary adenomas and identified AIP mutations have been mainly young males, with median age of emergence at 17.5 years, the tumor tends to be larger than in patients without AIP mutations and tumors were more often resistant to somatostatin analogs and required surgical intervention (80, 82, 83). The gene discussed is AIP; the disease is neoplasm.